Comparison Between Etest and Broth Microdilution Methods for Testing Itraconazole-Resistant Aspergillus fumigatus Susceptibility to Antifungal Combinations

被引:6
作者
Denardi, Laura Bedin [1 ,3 ]
Keller, Jessica Tairine [1 ,3 ]
de Azevedo, Maria Isabel [2 ,3 ]
Oliveira, Vanessa [3 ]
Piasentin, Fernanda Baldissera [1 ,3 ]
Severo, Cecilia Bittencourt [4 ]
Santurio, Janio Morais [2 ,3 ]
Alves, Sydney Hartz [1 ,3 ]
机构
[1] Univ Fed Santa Maria, Postgrad Program Pharmaceut Sci, Hlth Sci Ctr, BR-97105900 Santa Maria, RS, Brazil
[2] Univ Fed Santa Maria, Postgrad Program Pharmacol, Hlth Sci Ctr, Santa Maria, RS, Brazil
[3] Univ Fed Santa Maria, Mycol Res Lab, Santa Maria, RS, Brazil
[4] Univ Hlth Sci Porto Alegre UCSPA, Porto Alegre, RS, Brazil
关键词
Antifungal combinations; Aspergillus fumigatus; Etest; Broth microdilution; IN-VITRO INTERACTION; PULMONARY ASPERGILLOSIS; INVASIVE ASPERGILLOSIS; AZOLE RESISTANCE; AMPHOTERICIN-B; CASPOFUNGIN; VORICONAZOLE; EFFICACY; AGENTS; SYNERGY;
D O I
10.1007/s11046-017-0208-7
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
The checkerboard broth microdilution assay (BMD) is the most frequently used method for the in vitro evaluation of drug combinations. However, its use to evaluate the effect of antifungal drugs on filamentous fungi is sometimes associated with endpoint-reading difficulties, and different degrees of interaction are assigned to the same drug combination. We evaluated combinations of the azoles, itraconazole, posaconazole, and voriconazole, with the echinocandins, anidulafungin, caspofungin, and micafungin, against 15 itraconazole-resistant Aspergillus fumigatus clinical strains via the checkerboard BMD and Etest assay. Readings after 24 and 48 h, considering the two reading endpoints, the minimum inhibitory concentration (MIC) and minimum effective concentration (MEC), were performed for both methods. Our results showed that the correlation coefficients between the BMD and Etest methods were quite diverse to the drug combinations tested. The highest correlation coefficients of the Etest with the BMD assays (MEC and MIC reading) were the Etest-MIC reading at 24 h and the Etest-MEC reading at 48 h. Improvements in experimental conditions may increase the correlation between the two methods and ensure that Etest assay can be safely used in the evaluation of antifungal combinations against Aspergillus species.
引用
收藏
页码:359 / 370
页数:12
相关论文
共 46 条
[1]   Itraconazole in chronic cavitary pulmonary aspergillosis: a randomised controlled trial and systematic review of literature [J].
Agarwal, Ritesh ;
Vishwanath, Gella ;
Aggarwal, Ashutosh N. ;
Garg, Mandeep ;
Gupta, Dheeraj ;
Chakrabarti, Arunaloke .
MYCOSES, 2013, 56 (05) :559-570
[2]  
[Anonymous], COMBINATION ANTIFUNG
[3]   Development of Azole Resistance in Aspergillus fumigatus during Azole Therapy Associated with Change in Virulence [J].
Arendrup, Maiken Cavling ;
Mavridou, Eleftheria ;
Mortensen, Klaus Leth ;
Snelders, Eveline ;
Frimodt-Moller, Niels ;
Khan, Humara ;
Melchers, Willem J. G. ;
Verweij, Paul E. .
PLOS ONE, 2010, 5 (04)
[4]  
Arendrup MC, 2015, 931 EUCAST EDEF
[5]  
Canton E, 2004, Rev Esp Quimioter, V17, P48
[6]   Efficacy of voriconazole plus amphotericin B or micafungin in a guinea-pig model of invasive pulmonary aspergillosis [J].
Chandrasekar, PH ;
Cutright, JL ;
Manavathu, EK .
CLINICAL MICROBIOLOGY AND INFECTION, 2004, 10 (10) :925-928
[7]   Combined activity in vitro of caspofungin, amphotericin B, and azole agents against itraconazole-resistant clinical isolates of Aspergillus fumigatus [J].
Cuenca-Estrella, M ;
Gomez-Lopez, A ;
Garcia-Effron, G ;
Alcazar-Fuoli, L ;
Mellado, E ;
Buitrago, MJ ;
Rodriguez-Tudela, JL .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2005, 49 (03) :1232-1235
[8]  
Denning DW, 2011, FUTURE MICROBIOL, V6, P1229, DOI [10.2217/FMB.11.118, 10.2217/fmb.11.118]
[9]   Itraconazole resistance in Aspergillus fumigatus [J].
Denning, DW ;
Venkateswarlu, K ;
Oakley, KL ;
Anderson, MJ ;
Manning, NJ ;
Stevens, DA ;
Warnock, DW ;
Kelly, SL .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1997, 41 (06) :1364-1368
[10]   Invasive aspergillosis [J].
Denning, DW .
CLINICAL INFECTIOUS DISEASES, 1998, 26 (04) :781-803